General MedicationsINTRAVENOUSGeneric
AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER
MOXIFLOXACIN HYDROCHLORIDE
Standard Dose
400MG/250ML (1.6MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Key Takeaways
- Primary indication: Review priority: STANDARD Marketing status: Discontinued
- Approval overview AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 021277 (NDA).
- Review priority: STANDARD Marketing status: Discontinued Active ingredient MOXIFLOXACIN HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - 400MG/250ML (1.6MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BAYER HLTHCARE Submission history Latest submission status date: 2025-07-11 00:00:00.
Structured Monograph
Clinical summary
Approval overview AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 021277 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MOXIFLOXACIN HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - 400MG/250ML (1.6MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BAYER HLTHCARE Submission history Latest submission status date: 2025-07-11 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.